Does TOFACITINIB Cause Oedema? 1,543 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,543 reports of Oedema have been filed in association with TOFACITINIB (XELJANZ XR). This represents 1.0% of all adverse event reports for TOFACITINIB.
1,543
Reports of Oedema with TOFACITINIB
1.0%
of all TOFACITINIB reports
778
Deaths
977
Hospitalizations
How Dangerous Is Oedema From TOFACITINIB?
Of the 1,543 reports, 778 (50.4%) resulted in death, 977 (63.3%) required hospitalization, and 1,037 (67.2%) were considered life-threatening.
Is Oedema Listed in the Official Label?
Yes, Oedema is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Oedema?
RITUXIMAB (2,791)
PREDNISONE (2,721)
AMBRISENTAN (2,651)
METHOTREXATE (2,244)
ADALIMUMAB (2,141)
TOCILIZUMAB (1,836)
FOLIC ACID (1,781)
ABATACEPT (1,754)
TREPROSTINIL (1,705)
DICLOFENAC (1,691)
Which TOFACITINIB Alternatives Have Lower Oedema Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN